knowledge -WSS

knowledge

author：focus 2025-09-28 23:47:16 - browse：1

Stoke Therapeutics is still seeking an effective dose for an experimental drug to treat a severe form of childhood epilepsy, following the release of updated data Tuesday that showed disappointing reductions in convulsive seizure activity.

In the latest look at an ongoing mid-stage study, three monthly injections of the Stoke drug, called STK-001, given at a 45-mg dose, resulted in a median 18% reduction in convulsive seizure activity, compared to baseline.

The new analysis was conducted on 16 children diagnosed with a rare form of epilepsy called Dravet syndrome. Last November, in six patients, the drug showed a median 55% reduction in seizure activity.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

WSS

Reports of telehealth's death have been greatly exaggerated

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Addressing health care workers' trauma can help fight burnout

Study finds gene variants tied to breast cancer risk in Black women

Stanford president faces new allegations over 1999 paper

Stanford president faces new allegations over 1999 paper

focus

knowledge

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Stanford president faces new allegations over 1999 paper

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Stanford president faces new allegations over 1999 paper

United colonoscopy coverage change 'may cost lives,' doctors say

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

The high cost of giving birth even with insurance

Making the case for fair compensation in clinical trials

United colonoscopy coverage change 'may cost lives,' doctors say

H5N1 virus can be tracked in retail milk, scientists say

hotspot

Listen: More tumult at BIO & coercive care for sickle cell patients

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Awakening the world to the whoosh: A patient's crusade

Scrutiny of post

Hospitals struggle to profit from CAR

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

explore

entertainment

hotspot

focus